Showing results (1-10 of 277) with videos related to
Sort By:
Pageof 28
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2013
Hypersensitivity reactions associated with fidaxomicin useDmitri E Iarikov, John Alexander, Sumathi NambiarThe Pediatric Infectious Disease Journal|September 28, 2002
Change in epidemiology of health care-associated infections in a neonatal intensive care unitSumathi Nambiar, Nalini SinghACS Infectious Diseases|June 13, 2020
Achieving Regulatory Alignment for Anti-Infective Clinical TrialsSumathi Nambiar, Marco Cavaleri, Junko SatoJournal of the Pediatric Infectious Diseases Society|February 14, 2018
Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our ApproachGary J Noel, Sumathi Nambiar, John Bradley, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|May 17, 2003
Outbreak of invasive disease caused by methicillin-resistant Staphylococcus aureus in neonates and prevalence in the neonatal intensive care unitSumathi Nambiar, Loreen A Herwaldt, Nalini SinghJournal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|August 28, 2010
Low prevalence of primary HIV resistance in western MassachusettsDmitri E Iarikov, Melina Irizarry-Acosta, Claudia Martorell, et al.Southern Medical Journal|November 12, 2002
Are pediatricians adhering to principles of judicious antibiotic use for upper respiratory tract infections?Sumathi Nambiar, Richard H Schwartz, Michael J SheridanInfectious Diseases and Therapy|October 7, 2015
Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System DatabaseDmitri Iarikov, Ronald Wassel, John Farley, et al.Archives of Pediatrics & Adolescent Medicine|June 1, 2002
Antibiotic use for upper respiratory tract infections: how well do pediatric residents do?Sumathi Nambiar, Richard H Schwartz, Michael J SheridanPediatrics|March 18, 2009
Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse eventsJohn S Bradley, Ronald T Wassel, Lucia Lee, et al.Pageof 28